Glenmark Pharmaceuticals Ltd, a research-led global integrated pharmaceutical company, becomes one of the first companies to launch a bioequivalent version of Tiotropium Bromide dry powder inhaler under the brand name - Tiogiva, in UK for the treatment of chronic obstructive pulmonary disease (COPD).
- Read more about Glenmark launches bioequivalent of Tiotropium Bromide for treatment of COPD
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/glenmark-launches-bioequivalent-of-tiotropium-bromide-for-treatment-of-copd
No comments:
Post a Comment